The New Wave of Therapy: Organ Transplantation & Bio-Device

Date: June 18, 2016 @ 12:30 pm – @ 4:30 pm
Location: Li Ka-Shing Center, LK130, Stanford, CA 94305

Are you eager to learn the most advanced academic research in biomedical field? Do you want to disclose the secret of the most popular bio-device company in the Bay Area? Are you curious about how to commercialize the product from the lab bench? Chinese-American Biopharmacuetical Society with ACSSS-Postdoc Department brings you the workshop – The New Wave of Therapy – Organ Transplantation & Bio-device. Three top notch scientist, CEO, and entrepreneur will take you to a journey of tech and business brainstorming. June 18th at Stanford LKS center, we are waiting for you!

Keynote Speaker:

Prof. Hiromitsu Nakauchi, Stanford University

Title: “Organs niche” for Generation of Functional Organs from iPS Cells

Invited Speaker:

Ben Hwang, Chairman and CEO, Profusa. Inc.

Title: Know Thyself – How a Little Sensor That Works for More Than Two Years Can Change The

Way You Understand Your Body and Health

Andrew Lee, Co-Founder and Chief Scientific Officer, Stem Cell Theranostics

Date: 2016-06- 18 Saturday

Time: 12:30 pm to 4:30 pm

Location: Li Ka-Shing Center, LK130, Stanford, CA 94305

Registration Link: click here

Hiromitsu Nakauchi:

Prof. Nakauchi obtained a M.D. from Yokohama City University School of Medicine and a Ph.D.

in immunology from University of Tokyo Graduate School of Medicine. He isolated CD8 genes

during his post-doc period at the Laboratory of Prof. Leonard Herzenberg at Stanford

University. After returning to Japan, he started working on hematopoietic stem cells in his

laboratory at RIKEN. In 1994, he became Professor of Immunology at the University of Tsukuba

where he demonstrated that a single hematopoietic stem cell could reconstitute the entire

hematopoietic system, a definitive experimental proof for the “stemness”. Since April 2002, he

has been a Professor of Stem Cell Therapy in the Institute of Medical Science at The University

of Tokyo (IMSUT). In 2008, he was appointed Director of newly established Center for Stem Cell

Biology and Regenerative Medicine at IMSUT. Just recently, he returned to Stanford University

as a faculty to continue his stem cell research at the Institute of Stem Cell Biology and

Regenerative Medicine. Goals of his work are to translate discoveries in basic research into

practical medical applications.

Ben Hwang

Ben currently serves as the Chairman and Chief Executive Officer of Profusa, a company that

has created a wear-and- forget way to stream biochemical data from inside the body to a smart

device outside the body, truly transforming the way we measure health and wellness.

From his early exposure as an undergraduate research fellow at the lab of Leroy Hood at

Caltech, where the automated DNA sequencer was developed, to bringing cutting edge life

sciences tools to the market at Life Technologies Corporation (acquired by Thermo Fisher

Scientific, Inc.), Ben has seen first-hand the transformative impact that science and technology

have to change our world. Prior to Profusa, Ben served in a variety of leadership roles at Life

Technologies Corporation, including as President of the Asia Pacific Region and Head of the

qPCR Division. A former management consultant at McKinsey and Company, Ben earned his

M.A. and Ph.D. in Biology from the Johns Hopkins University.

Andrew Lee

Dr. Andrew Lee is a Co-Founder of Stem Cell Theranostics, Inc and was the company's founding

CEO before transitioning to Chief Scientific Officer. As an MD/PhD student at Stanford

University, Dr. Lee worked closely with Dr. Wu and Dr. Robbins, to develop the core disease

modeling technology that is the foundation of the company, publishing over 50 peer reviewed

research manuscripts on the use of stem cells for treatment of heart disease and drug

screening. Dr. Lee also the Co-Founder of StartX Med, the official Medical Innovation

Accelerator of Stanford University and Stanford Healthcare, which has 85+ portfolio companies

to date with cumulative funding of over $350M. His research has been supported by the

Howard Hughes Medical Institute, the FDA, and the American Heart Association as well as

several of the top 10 global pharmaceutical companies.

Hosted by: CABS and ACSSS-Postdoc Dept

Stanford student and postdoc or affiliates- FREE

CABS Member Access – FREE

Non Stanford/CABS Members – $20 (USD)

Registration Link: click here